<DOC>
	<DOCNO>NCT01370629</DOCNO>
	<brief_summary>This non-interventional prospective study post-authorization safety study ( PASS ) vernakalant conduct collect information normal condition use appropriate dosing , quantify possible medically significant risk associate use vernakalant real-world clinical practice .</brief_summary>
	<brief_title>Study Normal Conditions Use , Dosing , Safety Intravenous ( IV ) Administration Vernakalant ( MK-6621-049 )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>To treat intravenous vernakalant , independently study Participant and/or legal guardian willing provide inform consent and/or inform assent accord local regulation Enrollment investigational drug device clinical trial 30 day prior study enrolment . Participation another noninterventional drug device study registry permit .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>cardioversion</keyword>
</DOC>